Interview Series 20th March 2026
From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.
In this episode of From the Helm, Grady sits down with Neuren Pharmaceuticals (ASX:NEU) CEO Jon Pilcher, to recap on their major developments over the last 12 months in the US market, their guidance looking ahead for next financial year, and the company’s healthy cash balance.
-
Interview Series 20 Mar 2026
From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.
-
Interview Series 20 Mar 2026
From the helm: Amplia (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
-
Interview Series 20 Mar 2026
From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.
-
Interview Series 20 Mar 2026
From the helm: Saluda Medical (ASX:SLD), President & CEO, Barry Regan
-
Interview Series 20 Mar 2026
From the helm: Clarity Pharma (ASX:CU6), Chair, Alan Taylor & Senior Bell Potter Analyst John Hester
-
Interview Series 20 Mar 2026
From the helm: Mesoblast (ASX:MSB), Director, Silviu Itescu
-
Interview Series 20 Mar 2026
From the helm: 4DMedical (ASX:4DX), Founder & CEO, Andreas Fouras.
-
Interview Series 20 Mar 2026
From the helm: EBR Systems (ASX:EBR), President & CEO, John McCutcheon
-
Interview Series 15 Dec 2025
From the helm: Blackpearl Group Limited (ASX:BPG), Nick Lissette, CEO
-
Interview Series 29 Oct 2025
From the Helm: Rural Funds Group (ASX:RFF), Tim Sheridan, COO & James Powell, GM
-
Interview Series 28 Oct 2025
From the helm: SenSen Networks Limited (ASX: SNS), Dr Subhash Challa, CEO
-
Interview Series 1 Oct 2025
From the helm: Bhagwan Marine Limited (ASX:BWN), Andrew Wackett, Director of Finance